Document Detail

Multimodality Approach to Management of Stage III Non-Small Cell Lung Cancer.
MedLine Citation:
PMID:  23453337     Owner:  NLM     Status:  In-Data-Review    
Stage III non-small cell lung cancer represents a heterogeneous group of patients who are best managed with a multidisciplinary approach, including evaluation for surgical, radiation, and chemotherapeutic options.
Anthony Scarpaci; Priya Mitra; Doraid Jarrar; Gregory A Masters
Related Documents :
23037807 - Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of col...
21228697 - Time-window bias in case-control studies: statins and lung cancer.
24076237 - Trail on trial: preclinical advances in cancer therapy.
21148757 - Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
4006077 - A mutagenic metabolite produced by fusarium moniliforme isolated from linxian county, c...
22632577 - Understanding metabolic alterations in cancer cells: a promising new/old approach to er...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Surgical oncology clinics of North America     Volume:  22     ISSN:  1558-5042     ISO Abbreviation:  Surg. Oncol. Clin. N. Am.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9211789     Medline TA:  Surg Oncol Clin N Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  319-28     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Medical Oncology, Albert Einstein Medical Center Philadelphia, 5501 Old York Road, Philadelphia, PA 19141, USA. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multidisciplinary care of patients with early-stage breast cancer.
Next Document:  Multidisciplinary Management of Small Cell Lung Cancer.